SAPHO syndrome with Takayasu arteritis successfully treated with tofacitinib

Int J Rheum Dis. 2023 Jul;26(7):1381-1383. doi: 10.1111/1756-185X.14628. Epub 2023 Feb 22.

Abstract

SAPHO syndrome is an autoinflammatory disease with a variety of clinical manifestations, which may be accompanied by other systemic inflammatory diseases in addition to the typical manifestations of common synovitis, acne, pustulosis, hyperostosis, and osteitis. Here, we report the first case of SAPHO syndrome combined with Takayasu arteritis.

Keywords: SAPHO syndrome; Takayasu arteritis; tofacitinib.

Publication types

  • Case Reports

MeSH terms

  • Acne Vulgaris*
  • Acquired Hyperostosis Syndrome* / complications
  • Acquired Hyperostosis Syndrome* / diagnosis
  • Acquired Hyperostosis Syndrome* / drug therapy
  • Humans
  • Hyperostosis*
  • Osteitis*
  • Synovitis*
  • Takayasu Arteritis* / diagnosis
  • Takayasu Arteritis* / diagnostic imaging

Substances

  • tofacitinib